Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AT&T
T
|
+$877M |
| 2 |
Booking.com
BKNG
|
+$370M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$329M |
| 4 |
Boeing
BA
|
+$303M |
| 5 |
Walmart Inc
WMT
|
+$291M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$544M |
| 2 |
iShares MBS ETF
MBB
|
+$461M |
| 3 |
NVIDIA
NVDA
|
+$452M |
| 4 |
T-Mobile US
TMUS
|
+$426M |
| 5 |
Apple
AAPL
|
+$408M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.15% |
| 2 | Healthcare | 3.06% |
| 3 | Financials | 2.35% |
| 4 | Consumer Discretionary | 2.28% |
| 5 | Industrials | 1.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
KDMN
2001
DELISTED
Kadmon Holdings, Inc.
KDMN
| $19.6M | ﹤0.01% |
5,076,168
+713,530
| +16% | +$2.77M |
|
2002
CALL
Schrodinger
SDGR
$1.32B
| $19.6M | ﹤0.01% |
259,800
+38,600
| +17% | +$2.8M |
|
2003
CALL
Southern Company
SO
$107B
| $19.6M | ﹤0.01% |
324,200
-356,400
| -52% | -$22.8M |
|
|
OSH
2004
CALL
DELISTED
Oak Street Health, Inc.
OSH
| $19.6M | ﹤0.01% |
334,500
+193,500
| +137% | +$11.5M |
|
2005
CALL
Xtrackers Harvest CSI 300 China A-Shares ETF
ASHR
$1.58B
| $19.6M | ﹤0.01% |
483,100
-545,900
| -53% | -$21.8M |
|
2006
ZIM Integrated Shipping Services
ZIM
$3.39B
| $19.6M | ﹤0.01% |
435,794
+217,227
| +99% | +$8.37M |
|
|
SAGE
2007
PUT
DELISTED
Sage Therapeutics
SAGE
| $19.6M | ﹤0.01% |
344,600
+201,600
| +141% | +$14.3M |
|
2008
CALL
Mid-America Apartment Communities
MAA
$15.5B
| $19.6M | ﹤0.01% |
116,200
+38,300
| +49% | +$6.1M |
|
2009
CALL
ARK Blockchain & Fintech Innovation ETF
ARKF
$771M
| $19.6M | ﹤0.01% |
361,400
-228,400
| -39% | -$11.7M |
|
2010
CALL
Crocs
CROX
$6.32B
| $19.5M | ﹤0.01% |
167,500
+84,000
| +101% | +$8.27M |
|
2011
CALL
PACCAR
PCAR
$68.8B
| $19.5M | ﹤0.01% |
327,900
-160,350
| -33% | -$9.83M |
|
|
MNDT
2012
PUT
DELISTED
Mandiant, Inc. Common Stock
MNDT
| $19.5M | ﹤0.01% |
964,000
+69,500
| +8% | +$1.42M |
|
2013
Norfolk Southern
NSC
$75.1B
| $19.5M | ﹤0.01% |
73,439
-36,792
| -33% | -$10.2M |
|
2014
PUT
US Global Jets ETF
JETS
$824M
| $19.5M | ﹤0.01% |
805,300
+232,700
| +41% | +$6.08M |
|
2015
PUT
Southern Copper
SCCO
$156B
| $19.5M | ﹤0.01% |
330,226
+271,386
| +461% | +$17.4M |
|
2016
iShares Biotechnology ETF
IBB
$9.73B
| $19.4M | ﹤0.01% |
118,772
+50,100
| +73% | +$7.72M |
|
2017
Live Nation Entertainment
LYV
$43.9B
| $19.4M | ﹤0.01% |
221,871
+215,832
| +3,574% | +$18.5M |
|
2018
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
$17.1B
| $19.4M | ﹤0.01% |
190,562
-677,941
| -78% | -$69.1M |
|
2019
Xenon Pharmaceuticals
XENE
$6.03B
| $19.4M | ﹤0.01% |
1,043,543
+820,991
| +369% | +$15.1M |
|
2020
Wheaton Precious Metals
WPM
$61B
| $19.4M | ﹤0.01% |
440,547
-136,573
| -24% | -$6.08M |
|
|
SUNL
2021
DELISTED
Sunlight Financial Holdings, Inc.
SUNL
| $19.4M | ﹤0.01% |
98,757
+87,854
| +806% | +$17.6M |
|
2022
CALL
Cardinal Health
CAH
$54.7B
| $19.4M | ﹤0.01% |
339,800
+32,700
| +11% | +$1.91M |
|
2023
System1
SST
$24.6M
| $19.4M | ﹤0.01% |
195,939
+173,726
| +782% | +$17.3M |
|
2024
iShares GNMA Bond ETF
GNMA
$432M
| $19.4M | ﹤0.01% |
387,536
+222,973
| +135% | +$11.2M |
|
2025
Vodafone
VOD
$37.9B
| $19.4M | ﹤0.01% |
1,130,608
-36,664
| -3% | -$686K |
|
Similar funds
Ken Griffin's Q2 2021 Portfolio in Review
As of Q2 2021, Ken Griffin held 15,073 positions worth $447B, up 9.6% from $408B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Ken Griffin's Q2 2021 filing shows 1,965 new, 5,545 increased, 5,814 reduced and 1,500 closed positions. Its largest new stake was Coinbase: 1,010,057 shares worth $256M. The largest sale was Microsoft, an estimated $544M.
By sector, the portfolio is most concentrated in Technology at 3.2% of assets, down from 3.9% a quarter earlier, followed by Healthcare and Financials.
- Ken Griffin's largest Q2 2021 buy was Coinbase: 1,010,057 shares worth $256M.
- Ken Griffin added most to AT&T in Q2 2021, an estimated $877M increase.
- Ken Griffin's biggest Q2 2021 reduction was Microsoft, cutting an estimated $544M.
- Ken Griffin fully exited Varian Medical Systems, Inc. in Q2 2021, selling an estimated $197M.
- Ken Griffin's ten largest holdings make up 27% of its $447B portfolio in Q2 2021.
- Ken Griffin opened 1,965 new positions and closed 1,500 in Q2 2021.
- Ken Griffin's portfolio value rose 9.6% quarter-over-quarter to $447B.
Based on Citadel Advisors's 13F filing for Q2 2021, filed 16 Aug 2021.